Parathyroid carcinoma: evaluation and interdisciplinary management (Q35675202)

9 August 2017

Parathyroid carcinoma: evaluation and interdisciplinary management (English)

1 reference

9 August 2017

parathyroid carcinoma

1 reference

Rena Vassilopoulou-Sellin

inferred from title

author

4

object named as

Rena Vassilopoulou-Sellin

0 references

author name string

Gary L Clayman

1

1 reference

9 August 2017

Hernan E Gonzalez

2

1 reference

9 August 2017

Adel El-Naggar

3

1 reference

9 August 2017

Rena Vassilopoulou-Sellin

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

100

1 reference

9 August 2017

5

1 reference

9 August 2017

900-905

1 reference

Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation.

9 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

Primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Parathyroid carcinoma.A study of 70 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Parathyroid cancer: biology and management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Parathyroid carcinoma: sixteen new cases and suggestions for correct management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Inactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Parathyroid carcinoma—the princess margaret hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Diagnosis and treatment of patients with parathyroid carcinoma: An update and review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20089

7 January 2021

Identifiers

DOI

10.1002/CNCR.20089

1 reference

9 August 2017

1 reference